Vexim SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Edison Investment Research
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vexim SA Announces Details of International Subsidiaries
Vexim SA announced that it opened a subsidiary in Germany at the beginning of March 2012. As of June 30, 2012 the subsidiary had a Sales Director and a team of five salespeople in place. The Company also opened a subsidiary in Italy in June 2012. The Italian subsidiary is based in Milan and has a Sales Director and salesperson in place.
Latest Developments for Vexim SA
- Vexim announces 12-month results of study of performance of SpineJack in treating acute fresh traumatic vertebral compression fractures
- Vexim says SpineJack’s CE Mark expanded to all types of vertebral compression fractures
- Vexim SA announces results of study into use of Spinejack for vertebral compression factors
- Vexim SA announces results of study of SpineJack
Latest Key Developments in Medical
- SYSMEX CORP appoints John Kershaw as executive officer
- AngioDynamics Inc gives Q1, FY 2015 guidance; EPS guidance above analysts' estimates
- Eternity Healthcare and Shanghai Yin Jun Investment & Development establish joint venture operation for US$3 mln
- MiMedx Group Inc files its initial investigational new drug application
- Share this
- Digg this